Mei-Na Cao

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

National Center for Drug Screening

Mei-Na Cao is an author at Shanghai Institute of Materia Medica specializing in molecular oncology, biochemistry, and ubiquitin-proteasome proteolysis.

Publications per year

2012–2014

Publications

Curcusone D, a novel ubiquitin–proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth

Mei-Na Cao, Yubo Zhou, Anhui Gao et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2014 · 30 citations

Medicine, Oncology, Pharmacology +14

A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors

Yongliang Zhang, Zhenji Gan, Ping Huang et al. · Journal of Biological Chemistry · 2012 · 23 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

1–2 of 2